Atlas Trials

An Open Label, Prospective, Multicentre, Non-interventional Study of Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer

Clinical trial NCT02668380 · UNKNOWN

Trial details

NCT number
NCT02668380
Sponsor
Peking Union Medical College Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Metastatic Gastric Cancer
Start date
2015-09-01
Primary completion
2018-03-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.